In vivo administration of the anti-Tim1 antibody (clone 3B3) prevented the development of respiratory tolerance and increased pulmonary inflammation [13], suggesting that blocking Tim1 function may suppress type-2 responses such as those observed in allergic inflammation. This evidence concerns the gene HAVCR1 and inflammatory response.